WebMD News Brief

Dolly Parton Helped Fund COVID Vaccine Research

photo of dolly parton

Nov. 17, 2020 -- Did Dolly Parton cure COVID-19?

Not exactly, but the music and film legend donated $1 million to the coronavirus research that supported the development of the Moderna vaccine, according to The Guardian.

The company announced Monday that its vaccine is 94.5% effective, and a preliminary report of data published in TheNew England Journal of Medicine lists the Dolly Parton COVID-19 Research Fund in the funding acknowledgements section.

Parton donated funds to the Vanderbilt University Medical Center, which was involved in the research. She mentioned the donation in an Instagram post in April.

“My longtime friend Dr. Naji Abumrad, who’s been involved in research at Vanderbilt for many years, informed me that they were making some exciting advancements towards that research of the coronavirus for a cure,” she wrote. “I am making a donation of $1 million to Vanderbilt towards that research and to encourage people that can afford it to make donations,” she said.

Parton and Abumrad met when she was involved in a car accident in 2014 and was treated at Vanderbilt.

Her donation has also supported Vanderbilt’s convalescent plasma study, which is testing whether COVID-19 patients can be treated with antibodies from recovered patients. In addition, her funds have supported several research papers about the virus itself, The Guardian reported.

Parton has been busy in her career this year, too. In October, she released her third holiday collection, A Holly Dolly Christmas. And her seasonal musical, Dolly Parton’s Christmas on the Square, premieres on Netflix on Nov. 22.

Moderna is now applying for emergency use authorization from the FDA and has said it could potentially produce 1 billion doses by the end of 2021, The Guardian reported. The company is also submitting data to the regulatory agencies in the U.K., which has secured 5 million doses of the vaccine.

WebMD Health News Brief


The Guardian: “Dolly Parton partly funded Moderna Covid vaccine research.”

The New England Journal of Medicine: “An mRNA Vaccine against SARS-CoV-2 -- Preliminary Report.”

Instagram: @dollyparton, April 1, 2020.”

© 2020 WebMD, LLC. All rights reserved.